Moderna Raises $2 Billion to Accelerate Expansion into Cancer Treatments

Cambridge, Thursday, 27 August 2026.
Biotechnology firm Moderna is raising $2.0 billion to expand its growing oncology portfolio, protecting existing investors from potential stock dilution through a specialized financial hedge.